dipyridamole has been researched along with Tachyarrhythmia in 12 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Absolute regional MBF (milliliters per minute per gram) was measured by positron emission tomography and 13N-ammonia in resting conditions, during pacing-induced tachycardia, and after dipyridamole infusion (0." | 7.69 | Myocardial blood flow response to pacing tachycardia and to dipyridamole infusion in patients with dilated cardiomyopathy without overt heart failure. A quantitative assessment by positron emission tomography. ( Gallopin, M; Giorgetti, A; Lunardi, M; Michelassi, C; Neglia, D; Parodi, O; Pelosi, G; Pratali, L; Salvadori, P; Sambuceti, G, 1995) |
| "Increasing doses of adenosine were given by rapid intravenous bolus to seven patients with spontaneous supraventricular tachycardia." | 7.67 | Intravenous adenosine in the treatment of supraventricular tachycardia: a dose-ranging study and interaction with dipyridamole. ( Bernard, MS; Passani, SL; Routledge, PA; Stephens, MR; Watt, AH; Webster, J, 1986) |
| "We hypothesized that increased myocardial oxygen demand resulting from hypotension and reflex tachycardia unmasking a reduced endocardial myocardial blood flow (MBF) reserve is the mechanism of dipyridamole-induced regional dysfunction in chronic coronary artery disease." | 3.71 | Mechanism of inducible regional dysfunction during dipyridamole stress. ( Bin, JP; Coggins, MP; Kaul, S; Le, E; Pelberg, RA; Wei, K, 2002) |
| "Absolute regional MBF (milliliters per minute per gram) was measured by positron emission tomography and 13N-ammonia in resting conditions, during pacing-induced tachycardia, and after dipyridamole infusion (0." | 3.69 | Myocardial blood flow response to pacing tachycardia and to dipyridamole infusion in patients with dilated cardiomyopathy without overt heart failure. A quantitative assessment by positron emission tomography. ( Gallopin, M; Giorgetti, A; Lunardi, M; Michelassi, C; Neglia, D; Parodi, O; Pelosi, G; Pratali, L; Salvadori, P; Sambuceti, G, 1995) |
| "A case of severe myocardial ischaemia complicated by syncopal ventricular tachycardia during injection of Dipyridamole for stress Thallium myocardial scintigraphy in a coronary patient is reported." | 3.68 | [Severe ischemic ventricular arrhythmia during dipyridamole scintigraphy]. ( Barat, JL; Broustet, JP; Douard, H; Egloff, P, 1991) |
| "Increasing doses of adenosine were given by rapid intravenous bolus to seven patients with spontaneous supraventricular tachycardia." | 3.67 | Intravenous adenosine in the treatment of supraventricular tachycardia: a dose-ranging study and interaction with dipyridamole. ( Bernard, MS; Passani, SL; Routledge, PA; Stephens, MR; Watt, AH; Webster, J, 1986) |
| "Although anoxia releases noradrenaline from the heart the effect of anoxia on the VFT was not prevented by beta-adrenoceptor blockade with propranolol or pindolol or by previous treatment with reserpine." | 1.25 | The effect of anoxia on the ventricular fibrillation threshold in the rabbit isolated heart. ( Murnaghan, MF, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (66.67) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thormann, J | 1 |
| Mehta, J | 1 |
| Mehta, P | 1 |
| Neglia, D | 1 |
| Parodi, O | 1 |
| Gallopin, M | 1 |
| Sambuceti, G | 1 |
| Giorgetti, A | 1 |
| Pratali, L | 1 |
| Salvadori, P | 1 |
| Michelassi, C | 1 |
| Lunardi, M | 1 |
| Pelosi, G | 1 |
| Pennell, DJ | 1 |
| Manzara, CC | 1 |
| Underwood, SR | 1 |
| Longmore, DB | 1 |
| Bin, JP | 1 |
| Le, E | 1 |
| Pelberg, RA | 1 |
| Coggins, MP | 1 |
| Wei, K | 1 |
| Kaul, S | 1 |
| Murnaghan, MF | 1 |
| Egloff, P | 1 |
| Douard, H | 1 |
| Barat, JL | 1 |
| Broustet, JP | 1 |
| Yabe, T | 1 |
| Doi, Y | 1 |
| Yonesawa, Y | 1 |
| Takada, J | 1 |
| Yamada, M | 1 |
| Odawara, H | 1 |
| Ozawa, T | 1 |
| Jenkins, JR | 1 |
| Belardinelli, L | 1 |
| Watt, AH | 1 |
| Bernard, MS | 1 |
| Webster, J | 1 |
| Passani, SL | 1 |
| Stephens, MR | 1 |
| Routledge, PA | 1 |
| Wilcken, DE | 1 |
| Paoloni, HJ | 1 |
| Eikens, E | 1 |
| Botti, G | 1 |
| Visioli, O | 1 |
| Ambanelli, U | 1 |
2 trials available for dipyridamole and Tachyarrhythmia
| Article | Year |
|---|---|
Optimization of magnetic resonance imaging parameters for left ventricular wall motion studies at 0.5 T.
Topics: Adult; Aged; Cardiotonic Agents; Dipyridamole; Dobutamine; Female; Heart Rate; Humans; Magnetic Reso | 1998 |
Evidence for intravenous dipyridamole (persantin) producing a "coronary steal" effect in the ischaemic myocardium.
Topics: Adolescent; Adult; Cardiac Output; Cardiovascular System; Clinical Trials as Topic; Coronary Disease | 1971 |
10 other studies available for dipyridamole and Tachyarrhythmia
| Article | Year |
|---|---|
[Effect of tachycardia on hemodynamics and coronary circulation. Different relevance of ventricular tachycardias for healthy persons, coronary patients and patients with left heart hypertrophy].
Topics: Aortic Valve; Aortic Valve Stenosis; Cardiac Pacing, Artificial; Cardiomegaly; Coronary Circulation; | 1984 |
Significance of platelet function and thromboxane B2 levels across the human myocardial vascular bed.
Topics: Arteriosclerosis; Aspirin; Coronary Circulation; Coronary Disease; Coronary Vessels; Dipyridamole; H | 1981 |
Myocardial blood flow response to pacing tachycardia and to dipyridamole infusion in patients with dilated cardiomyopathy without overt heart failure. A quantitative assessment by positron emission tomography.
Topics: Adult; Aged; Cardiac Output, Low; Cardiac Pacing, Artificial; Cardiomyopathy, Dilated; Coronary Circ | 1995 |
Mechanism of inducible regional dysfunction during dipyridamole stress.
Topics: Animals; Blood Pressure; Coronary Circulation; Coronary Stenosis; Dipyridamole; Dogs; Echocardiograp | 2002 |
The effect of anoxia on the ventricular fibrillation threshold in the rabbit isolated heart.
Topics: Adenosine; Animals; Dipyridamole; Electrocardiography; Heart; Heart Rate; Hypoxia; In Vitro Techniqu | 1975 |
[Severe ischemic ventricular arrhythmia during dipyridamole scintigraphy].
Topics: Aged; Coronary Angiography; Coronary Disease; Dipyridamole; Electrocardiography; Female; Heart; Hear | 1991 |
[Assessment of prognosis of patients with ventricular tachycardia: role of the underlying heart disease].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cardiac Catheterization; Cardiomyopathy, Dilated; Cardio | 1989 |
Atrioventricular nodal accommodation in isolated guinea pig hearts: physiological significance and role of adenosine.
Topics: Acetylcholine; Adenosine; Animals; Atrioventricular Node; Atropine; Dipyridamole; Guinea Pigs; Heart | 1988 |
Intravenous adenosine in the treatment of supraventricular tachycardia: a dose-ranging study and interaction with dipyridamole.
Topics: Adenosine; Adult; Aged; Dipyridamole; Dose-Response Relationship, Drug; Drug Interactions; Drug Ther | 1986 |
[On the anti-arrhythmia activity of a new adrenergic blocking agent].
Topics: Adult; Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Bradycardia; Digitalis Glycosides; Dipyridam | 1966 |